RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Procter & Gamble Health Stock

Procter & Gamble Health Revenue 2025

Procter & Gamble Health Revenue

12.8 B INR

Ticker

PGHL.NS

ISIN

INE199A01012

In 2025, Procter & Gamble Health's sales reached 12.8 B INR, a 11.16% difference from the 11.51 B INR sales recorded in the previous year.

The Procter & Gamble Health Revenue history

YEARREVENUE (undefined INR)GROSS MARGIN (%)
2026e13.8154,40
2025e12.858,69
202411.5165,24
202312.364,68
202211.1463,13
202110.0965,81
202013.5660,52
201911.5567,09
20188.4960,66
20177.1256,35
201610.351,62
20159.447,96
20148.6846,89
20137.9847,24
20126.8752,83
20115.953,36
20105.1255,22
20094.7352,15
20083.954,71
20073.1559,12
20063.357,72
20053.9754,68

Procter & Gamble Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Procter & Gamble Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Procter & Gamble Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Procter & Gamble Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Procter & Gamble Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Procter & Gamble Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Procter & Gamble Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Procter & Gamble Health’s growth potential.

Procter & Gamble Health Revenue, EBIT and net profit per share

DateProcter & Gamble Health RevenueProcter & Gamble Health EBITProcter & Gamble Health Net Income
2026e13.81 B undefined3.69 B undefined2.71 B undefined
2025e12.8 B undefined3.31 B undefined2.42 B undefined
202411.51 B undefined2.82 B undefined2.01 B undefined
202312.3 B undefined3.09 B undefined2.29 B undefined
202211.14 B undefined2.47 B undefined1.93 B undefined
202110.09 B undefined2.17 B undefined1.77 B undefined
202013.56 B undefined2.9 B undefined2.54 B undefined
201911.55 B undefined2.41 B undefined2.05 B undefined
20188.49 B undefined1.26 B undefined8.39 B undefined
20177.12 B undefined752 M undefined939 M undefined
201610.3 B undefined994 M undefined791 M undefined
20159.4 B undefined613 M undefined536 M undefined
20148.68 B undefined463 M undefined432 M undefined
20137.98 B undefined669 M undefined559 M undefined
20126.87 B undefined967 M undefined784 M undefined
20115.9 B undefined647 M undefined637 M undefined
20105.12 B undefined697 M undefined632 M undefined
20094.73 B undefined533 M undefined655 M undefined
20083.9 B undefined440 M undefined630 M undefined
20073.15 B undefined604 M undefined688 M undefined
20063.3 B undefined-15 M undefined1.33 B undefined
20053.97 B undefined699 M undefined788 M undefined

Procter & Gamble Health stock margins

The Procter & Gamble Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Procter & Gamble Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Procter & Gamble Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Procter & Gamble Health's sales revenue. A higher gross margin percentage indicates that the Procter & Gamble Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Procter & Gamble Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Procter & Gamble Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Procter & Gamble Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Procter & Gamble Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Procter & Gamble Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Procter & Gamble Health Margin History

Procter & Gamble Health Gross marginProcter & Gamble Health Profit marginProcter & Gamble Health EBIT marginProcter & Gamble Health Profit margin
2026e65.24 %26.69 %19.62 %
2025e65.24 %25.83 %18.92 %
202465.24 %24.46 %17.46 %
202364.68 %25.12 %18.66 %
202263.13 %22.2 %17.27 %
202165.81 %21.54 %17.53 %
202060.52 %21.37 %18.74 %
201967.09 %20.86 %17.77 %
201860.66 %14.86 %98.79 %
201756.35 %10.57 %13.2 %
201651.62 %9.65 %7.68 %
201547.96 %6.52 %5.71 %
201446.89 %5.34 %4.98 %
201347.24 %8.39 %7.01 %
201252.83 %14.07 %11.41 %
201153.36 %10.97 %10.8 %
201055.22 %13.61 %12.34 %
200952.15 %11.27 %13.84 %
200854.71 %11.3 %16.17 %
200759.12 %19.19 %21.86 %
200657.72 %-0.46 %40.49 %
200554.68 %17.63 %19.87 %

Procter & Gamble Health Aktienanalyse

What does Procter & Gamble Health do?

Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion. The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products. The different divisions of Procter & Gamble Health Ltd. include the following areas: Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy. Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio. Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area. Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands. Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette. Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell. In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide. In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility. Procter & Gamble Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Procter & Gamble Health's Sales Figures

The sales figures of Procter & Gamble Health originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Procter & Gamble Health’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Procter & Gamble Health's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Procter & Gamble Health’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Procter & Gamble Health stock

How much revenue did Procter & Gamble Health generate this year?

Procter & Gamble Health has achieved a revenue of 12.8 B INR this year.

How much was the turnover of the company Procter & Gamble Health compared to the previous year?

The revenue of Procter & Gamble Health has increased by 11.16% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Procter & Gamble Health?

The revenue of Procter & Gamble Health is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Procter & Gamble Health measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Procter & Gamble Health so important for investors?

The revenue of Procter & Gamble Health is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Procter & Gamble Health pay?

Over the past 12 months, Procter & Gamble Health paid a dividend of 270 INR . This corresponds to a dividend yield of about 5.29 %. For the coming 12 months, Procter & Gamble Health is expected to pay a dividend of 306.55 INR.

What is the dividend yield of Procter & Gamble Health?

The current dividend yield of Procter & Gamble Health is 5.29 %.

When does Procter & Gamble Health pay dividends?

Procter & Gamble Health pays a quarterly dividend. This is distributed in the months of December, March, December, March.

How secure is the dividend of Procter & Gamble Health?

Procter & Gamble Health paid dividends every year for the past 14 years.

What is the dividend of Procter & Gamble Health?

For the upcoming 12 months, dividends amounting to 306.55 INR are expected. This corresponds to a dividend yield of 6.01 %.

In which sector is Procter & Gamble Health located?

Procter & Gamble Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Procter & Gamble Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Procter & Gamble Health from 3/7/2025 amounting to 80 INR, you needed to have the stock in your portfolio before the ex-date on 2/21/2025.

When did Procter & Gamble Health pay the last dividend?

The last dividend was paid out on 3/7/2025.

What was the dividend of Procter & Gamble Health in the year 2024?

In the year 2024, Procter & Gamble Health distributed 145 INR as dividends.

In which currency does Procter & Gamble Health pay out the dividend?

The dividends of Procter & Gamble Health are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Procter & Gamble Health

Our stock analysis for Procter & Gamble Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procter & Gamble Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.